Cancer;Kidney Cancer;Lung Cancer;Metastasis

Risk model based on routine blood work predicts treatment response and survival of metastatic cancer patients treated with immune checkpoint inhibitors

[ad_1] Newswise — A risk model developed by researchers can help to identify cancer patients who could benefit from immune…